Supplementary Figure 1 SK-N-SH Vehicle GW9662 Number of cells

Slides:

Advertisements

Similar presentations

Supplementary Figure 1: Co-treatment with SAHA and PLX4720 increases the level of a ~50kD fragment of PARP. Whole cell lysates from MM200 and Sk-Mel-28.

Advertisements

Nuclear-free preparation Control Nuclear-free preparation DMSO Whole cell preparation Control Whole cell preparation DMSO 66 kD Supplementary Fig. 1. Western.

SIRTs inhibitor: Sirtinol Supplementary Figure S3A Supplementary Figure S3 Sirtinol but not EX527 or PDF-170 significantly enhances ithe cytotoxic and.

Figure 6. Biochemical analysis of mTORC1- and mTORC2-dependent signaling in response to UVB. iRicKO cells were treated with vehicle or with 4OHT for 3.

B A P-AXL P-AXL AXL AXL P-MET P-MET MET MET P-Akt-473 P-Akt-473 AKT

Supplementary Figure 1 Sensitive Resistant Cell Count Propidium Iodide

From: Regulation of Tenon's Capsule Fibroblast Cell Proliferation by the Opioid Growth Factor and the Opioid Growth Factor Receptor Axis Invest. Ophthalmol.

Supplemental Figure 2 A B vehicle

ABAE positive cells 6h after treatment

A B SK-N-SH cells, 24 h after irradiation SK-N-SH cells, 48 h

a b c ** ** ** ** * * * P450arom mRNA Trascript Levels (Fold)

Online Gifts Buy for wishes happy mother's day to yours choice and with happy gifts find here:

HER2 mutations V777L, D769H, V842I, G309A induce gain-of-function over HER2 WT in MCF10A mammary epithelial cells. HER2 mutations V777L, D769H, V842I,

Volume 140, Issue 2, Pages e2 (February 2011)

The TCL1 oncoprotein inhibits activation-induced cell death by impairing PKCθ and ERK pathways by Gilles Despouy, Marjorie Joiner, Emilie Le Toriellec,

A Novel IMP1 Inhibitor, BTYNB, Targets c-Myc and Inhibits Melanoma and Ovarian Cancer Cell Proliferation Lily Mahapatra, Neal Andruska, Chengjian Mao,

MK-8776, a novel Chk1 inhibitor, exhibits an improved radiosensitizing effect compared to UCN-01 by exacerbating radiation-induced aberrant mitosis Motofumi.

Kynurenine Increases Matrix Metalloproteinase-1 and -3 Expression in Cultured Dermal Fibroblasts and Improves Scarring In Vivo Yunyuan Li, Ruhangiz T.

Sebastian Trousil, Shuang Chen, Chan Mu, Fiona M

a b MCF-7 TR2 MCF-7 TR2 (Fold change) MTT Assay , (Fold change)

Volume 17, Issue 4, Pages (April 2010)

Supplementary Figure S1

Supplemental Figure % of viable cells 10 5 RHPS4 RHPS4+GPI

Neal X. Chen, Kalisha D. O'Neill, Danxia Duan, Sharon M. Moe

Volume 17, Issue 4, Pages (April 2010)

Tumor necrosis factor α up-regulates endometrial milk fat globule–epidermal growth factor 8 protein production via nuclear factor κB activation, resulting.

What number is the arrow pointing at?

A LAN6 CHLA90 CHLA15 SK-N-RA DMSO 13-cis RA

Supplementary Fig. S1 * * * * * * * * * * WS (µg/ml) + H2O2 (500 µM)

Nicholas D. James, Jim W. Growcott European Urology Supplements

The TRAF-Interacting Protein (TRIP) Is a Regulator of Keratinocyte Proliferation Stéphanie Almeida, Stephan Ryser, Magdalena Obarzanek-Fojt, Daniel Hohl,

Monika Jost, Csaba Kari, Ulrich Rodeck

Volume 132, Issue 5, Pages (May 2007)

KIF1Bβ promotes DHX9 nuclear localization.

Carrie Hayes Sutter, Kristin M

Activation of miR‐21‐3p by PPARβ/δ requires activation of the TGFβ receptor Activation of miR‐21‐3p by PPARβ/δ requires activation of the TGFβ receptor.

A genome-wide RNAi pooled screen identifies NF1 as a key determinant of RAF inhibitor sensitivity in melanoma cells. A genome-wide RNAi pooled screen identifies.

Volume 61, Issue 6, Pages (June 2002)

Green Tea Polyphenol Epigallocatechin-3-Gallate Suppresses Collagen Production and Proliferation in Keloid Fibroblasts via Inhibition of the STAT3-Signaling.

Leto et al., Supplementary Figure S3

A B Supplementary Figure S1 PC3 cells Vehicle 3β-Adiol

YAP1 and IGF2BP3 regulate each other during fetal programming.

Volume 67, Issue 6, Pages (June 2005)

pY-Tie2 (IP with anti-Tie2) Tie2 P-RET RET P-KIT KIT GAPDH P-AXL AXL

Ken Inoki, Masakazu Haneda, Shiro Maeda, Daisuke Koya, Ryuichi Kikkawa

Hidetoshi Takahashi, Akemi Ishida-Yamamoto, Hajime Iizuka

Supplementary Figure 5: Effect of S48168 on normalized organ and skeletal muscle weights after 12 weeks of treatment for all the experimental groups from.

Supplementary Figure S1

Immune-mediated tumor control by necroptotic cells requires NF-κB activation within dying cells but not MLKL-mediated cell lysis and DAMP release. Immune-mediated.

Synergistic interaction of Activin and canonical Wnt/β-catenin signaling pathways in the anterior PS/endoderm specification during hES cell differentiation.

Activation of the MAPK/Erk cascade is involved in the formation of functional synapses between B2 neurons. Activation of the MAPK/Erk cascade is involved.

MW (kDa) 2 µg 0.5 µg Supplementary Figure S1. SDS-PAGE under reducing condition analysis (Coomassie brilliant blue staining) of.

GR cells are dependent upon sustained CDC25C signaling as pharmacologic or genetic inhibition of CDC25C induce synthetic lethality. GR cells are dependent.

EGCG inhibits cell survival and growth of EFT cell lines but not of HBMECs. A, dose-responsive curves of fractional survival of EFT cells (TC32 and TC71)

Suppression of melanoma cell proliferation in response to kinase inhibitors. Suppression of melanoma cell proliferation in response to kinase inhibitors.

Selective delivery of pIC/PPHAffibody decreases the survival of HER2-overexpressing cells. Selective delivery of pIC/PPHAffibody decreases the survival.

Discovery of Gö6976-related potent reversible EGFR T790M inhibitors.

PNU enhances Ca2+ flux mediated by an engineered variant of the human α7 nAChR. PNU enhances Ca2+ flux mediated by an engineered variant.

Five-day exposure to decitabine (DAC) sensitizes cells to doxorubicin (Doxo). Five-day exposure to decitabine (DAC) sensitizes cells to doxorubicin (Doxo).

MAPK/ERK signaling regulates TLR4 gene expression in response to BRAFV600E. MAPK/ERK signaling regulates TLR4 gene expression in response to BRAFV600E.

AKT activation in HCC2429 is SRC- but not Notch-dependent.

Complete Vehicle Systems.

Validation of MYC-driven drug responses.

MTOR kinase inhibition–induced reactivation of AKT substrates is HER2 and PI3K dependent. mTOR kinase inhibition–induced reactivation of AKT substrates.

IL-1 and PGE2 mediate GRO-α, IL-6, and IL-8, but not RANTES induction in carcinoma cell–MSC coculture. IL-1 and PGE2 mediate GRO-α, IL-6, and IL-8, but.

Ceritinib is a potent ALK inhibitor in crizotinib-naïve models.

ARQ 531 is cytotoxic to CLL cells, decreases NF-κB function, and inhibits migration. ARQ 531 is cytotoxic to CLL cells, decreases NF-κB function, and inhibits.

MET activation confers resistance to cetuximab (Cmab) or panitumumab (Pmab) in colon cancer cell lines in vitro and in vivo. MET activation confers resistance.

DHA and dietary n-3 PUFAs inhibit endometrial cancer cell growth in vitro and in xenograft models. DHA and dietary n-3 PUFAs inhibit endometrial cancer.

Presentation transcript:

Supplementary Figure 1 SK-N-SH Vehicle GW9662 Number of cells 1 2 3 5 x106 SK-N-SH 4 3 Vehicle GW9662 Number of cells 2 1 1 2 3 5 7 Day Supplementary Figure 1. Growth of SK-N-SH cells in the presence of absence of GW9962 (15 M). Number of viable cells were measured on the indicated.

Supplementary Figure 2 x105 4.5 4 3.5 3 Number of cells UT 2.5 GW9662 2 BAY-11-7082 1.5 Both 1 0.5 1 2 3 4 Day Supplementary Figure 2. No cytotoxicity effect of PPAR antagonist (GW9662) and NF- inhibitor (BAY-11-7082) in MCF10A cells. cells were subject to treated (indicated by arrow) by replacing with new media containing either GW9662 (15 M) or BAY-11-7082 (5 M) or both. Cells not treated with either chemicals (UT) were used as comparison. Number of viable cells were measured on 24 hour (Day 2), 48 hour (Day 3) and 72 hour (Day 4).